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Purpose: Seasons and weather conditions might influence participation in physical activity
and contribute to differences between countries. This study aimed at investigating whether
there were differences in physical activity levels between Norwegian, Danish and Australian
people with chronic obstructive pulmonary disease (COPD), and establishing if any varia-
tions in physical activity were attributable to seasons.
Patients and methods: Across-sectional studywhere study subjects were peoplewith COPD
who participated in two separate clinical trials: the iTrain study (Norway, Denmark, and
Australia) and the HomeBase study (Australia). Physical activity was objectively assessed with
an activity monitor; variables were total energy expenditure, number of daily steps, awake
sedentary time, light, and moderate-to-vigorous intensity physical activity. Differences in physi-
cal activity between countries and seasons were compared, with adjustment for disease severity.
Results: In total, 168 participants were included from Norway (N=38), Denmark (N=36) and
Australia (N=94). After controlling for disease severity, time spent in awake sedentary time was
greater in Danish participants compared to the other countries (median 784 minutes/day [660–952]
vs 775 minutes/day [626–877] for Norwegians vs 703 minutes/day [613–802] for Australians,
P=0.013), whilst time spent in moderate to vigorous physical activity was lower (median 21
minutes/day [4–73] vs 30 minutes/day [7–93] for Norwegians vs 48 minutes/day [19–98] for
Australians, P=0.024). Participants walked more during summer (median 3502 [1253–5407]
steps/day) than in spring (median 2698 [1613–5207] steps/day), winter (median 2373 [1145–
4206] steps/day) and autumn (median 1603 [738–4040] steps/day), regardless of geography. The
median difference between summer and other seasons exceeded the minimal clinically important
difference of 600 steps/day. However, the differences were not statistically significant (P=0.101).
Conclusion: After controlling for disease severity, Danish participants spent more time in an
awake sedentary state and less time in moderate to vigorous physical activity than their counter-
parts in Norway and Australia. People with COPD increased their physical activity in summer
compared to other seasons. Weather conditions and seasonal variations may influence outcomes
in clinical trials and health registries measuring physical activity over time, irrespective of the
interventions delivered, and should be taken into account when interpreting results.
Keywords: chronic obstructive pulmonary disease, activity monitoring, population
comparison, seasons, weather
Introduction
Physical inactivity contributes significantly to morbidity and mortality worldwide.1
People with chronic obstructive pulmonary disease (COPD) are less physically
active than healthy age-matched controls,2,3 and physical inactivity and sedentary
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behavior are associated with an increased risk of all-cause
mortality in this group.4–7 Inactivity is also thought to lead
to a more rapid progression of COPD and the development
of comorbidities in these individuals.4–6,8 Conversely, dis-
ease progression, exacerbations and comorbidities may
also lead to decreased physical activity.5 Given the inter-
play between physical activity and health in this group,9 a
physically active lifestyle is recommended for all indivi-
duals with COPD.10
In healthy people, physical inactivity varies between
countries, with populations from high-income countries
being the most inactive.11 Socioeconomic factors may
also have some influence on physical activity among peo-
ple with COPD. In a study comparing physical activity
levels among people with COPD with different socioeco-
nomic and ethnic characteristics, the percentage of
Austrians performing less than 30 minutess of moderate
to vigorous physical activity per day was 48% compared
with 23% in a disease severity-matched Brazilian group.12
Seasonal variations in terms of duration of daylight time
and weather conditions might also affect physical activity
levels and could be a confounder when investigating physical
activity in COPD.13–17 Winter months with cold tempera-
tures have an impact on lung function and the risk of
exacerbations.18,19 However, extremes of hot weather have
also been linked to increased morbidity among those with
COPD.19 In a study of 190 people with COPD in Canada,
temperature was positively related to the number of steps per
day, while precipitation was negatively related.16 In one
study comparing physical activity levels between summer
and winter within the same group of people with COPD in
Belgium and Brazil, physical activity levels varied consider-
ably according to the season, even when climate differences
between winter and summer were less pronounced.17
There are a growing number of studies showing that
physical activity levels among people with COPD can vary
between countries and that seasonal variations can influ-
ence physical activity behavior in patients from different
world regions. However, the body of evidence is still
limited, and variations in physical activity levels among
people with COPD across countries and seasons still
deserves further investigation.
The objectives of this study were: (1) to investigate
whether there were differences in physical activity levels
between Norwegian, Danish, and Australian people with
COPD and (2) to establish if any variation in physical
activity levels was attributable to the seasons (winter,
spring, summer, autumn). We hypothesized that Nordic
patients might have lower physical activity levels than
Australian patients due to lower average temperatures.
We also hypothesized a difference in physical activity
levels between winter and summer. Exploring physical
activity patterns and seasonal variations in physical activ-
ity across countries can support interpretation of data from
clinical studies where physical activity is an outcome.
Material and methods
Study subjects and design
Study subjects were a cross-sectional convenience sample of
participants in two separate clinical trials, the iTrain study
and the HomeBase study. Baseline data were used for this
analysis. The iTrain study was an international multicenter
randomized controlled trial on telerehabilitation for people
with COPD in Norway, Denmark and Australia.20 The
HomeBase study was a randomized controlled trial investi-
gating home-based pulmonary rehabilitation for people with
COPD in Australia.21 Common inclusion criteria for both
trials were a confirmed diagnosis of COPD (forced expira-
tory volume in 1 second over forced vital capacity ratio/
forced vital capacity (FEV1/FVC) ≤0.70) and age between
40 and 80 years. Participants in these trials were recruited
during all seasons. Participants in the HomeBase study were
recruited between March 2013 and March 2014. Physical
activity was measured in a subgroup of participants recruited
from the time when additional funding became available
until the end of the trial. The iTrain study recruited from
October 2014 to December 2016. The current study included
physical activity data in a subgroup of participants recruited
from the beginning of the trial to August 2016 when data
analysis was initiated.
Settings
The Tromsø area where the Norwegian participants lived
has a humid subarctic continental climate with cool sum-
mers and snowy winters. The temperature typically varies
from −7°C to 15°C over the course of a year, and is rarely
below −13°C or above 21°C. The warm season lasts from
June 14 to September 3 with an average daily high tem-
perature above 12°C. The warmest month of the year is
July. The cold season lasts from November 16 to March 31
with an average daily high temperature below 1°C. The
coldest month of the year is February.22
The Danish participants lived in the area near Esbjerg,
which has a mild humid temperate climate characterized
by warm summers. Over the course of a year, the tem-
perature typically varies from −2°C to 21°C and is rarely
Hoaas et al Dovepress
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below −8°C or above 26°C. The warm season lasts from
May 27 to September 10 with an average daily high
temperature above 18°C. The warmest month of the year
is July. The cold season lasts from December 4 to March 5
with an average daily high temperature below 6°C. The
coldest month of the year is February.23
The area around Melbourne, where the Australian parti-
cipants were situated, also has a mild humid temperate cli-
mate with warm summers and no dry season. The
temperature typically varies from 6°C to 26°C over the
course of a year and is rarely below 3°C or above 34°C.
The warm season lasts from December 20 to March 14 with
an average daily high temperature above 24°C. The warmest
month of the year is January. The cold season lasts fromMay
22 to September 3 with an average daily high temperature
below 15°C. The coldest month of the year is July.24
Data collection and analysis
Data on participant characteristics included country, gen-
der, age, body mass index (BMI), number of comorbid-
ities, smoking history, lung function measured by
spirometry,25 disease severity (I to IV) according to the
former staging system of the Global Initiative for Chronic
Obstructive Lung Disease (GOLD),10 use of long-term
oxygen therapy (LTOT), dyspnea measured with the mod-
ified Medical Research Council dyspnea scale (MMRC),26
and functional walking capacity measured by the 6 min-
utes walk distance (6MWD).27
Physical activity levels were objectively assessed at base-
line, prior to any implementation of interventions, with an
activity monitor (SenseWear Armband, BodyMedia, Inc.,
Pittsburgh, PA. USA) which has been also validated for
people with COPD.28 The SenseWear Armband is an
advanced, lightweight microprocessor-based device that is
worn over the left triceps.28 Participants were asked to wear
the activity monitor continuously for 7 consecutive days,
except for personal hygiene or other water-based activities.
Minute-by-minute output was exported using SenseWear
Professional version 8.0 software (BodyMedia, Inc). The
first and the last day of recording were excluded from ana-
lysis to avoid incomplete measurements which could intro-
duce a bias. Samples without at least one weekend day or
without 5 valid days with wear time ≥12 hours days were
excluded.13,29 All valid days were included in the analysis.
Physical activity outcomes were measured total energy
expenditure in kilojoules (kJ) per day, total number of steps
per day, minutes of awake sedentary time per day, total
minutes of light intensity physical activity per day (LIPA),
total minutes of moderate-to-vigorous physical activity
(MVPA) per day, and total minutes in ≥10 minute bouts of
moderate-to-vigorous physical activity (MVPA bouts).
Awake sedentary time was defined as activity where the
metabolic equivalent was ≤1.5 METs, and measured sleep
was excluded.29 Non-wear time was not included in mea-
surement of sedentary behavior. Any activity between 1.5
and 3 METs was defined as LIPA, and activity measured to
≥3 METs was considered MVPA.30
Differences in physical activity levels were compared
across the three countries (Norway, Denmark and
Australia). Seasonal variations were defined according to
the meteorological seasons in the Northern Hemisphere and
the Southern Hemisphere. The four seasons were defined as
follows: winter (from December 1 to February 28 in Norway
and Denmark, from June 1 to August 31 in Australia), spring
(from March 1 to May 31 in Norway and Denmark, from
September 1 to November 30 in Australia), summer (from
June 1 to August 31 in Norway and Denmark, from
December 1 to February 28 in Australia), and autumn
(from September 1 to November 30 in Norway and
Denmark, from March 1 to May 31 in Australia).
Statistical analyses
Descriptive data were reported as median and IQR for
continuous variables, and counts and percentages for cate-
gorical variables. Normality of distribution was tested with
the Kolmogorov–Smirnov test. Differences in participant
characteristics between the three countries were compared
with Kruskal–Wallis test for continuous variables and chi-
squared test for categorical variables. A Mann–Whitney
test was used as a post hoc test to discover which specific
means differed when the overall Kruskal–Wallis result was
significant. Log transformation (used for energy expendi-
ture) and cubic root transformation (used for steps, LIPA
and MVPA time) were applied to the physical activity
variables with a non-normal distribution in order to obtain
normally distributed data so that parametric methods for
statistical analyses could be performed. No transformation
nor statistical analyses were applied to time in MVPA
bouts due to the high number of zero values. Values
reported in tables are original median and IQR values.
Differences in physical activity variables between coun-
tries and seasons were compared with one-way ANOVA.
A Tukey post hoc test was used to discover which specific
means differed where the overall ANOVA result was sig-
nificant. Between country differences were also adjusted
for disease severity (FEV1%) using one-way ANCOVA.
Dovepress Hoaas et al
International Journal of Chronic Obstructive Pulmonary Disease 2019:14 submit your manuscript | www.dovepress.com
DovePress
1221
 
In
te
rn
at
io
na
l J
ou
rn
al
 o
f C
hr
on
ic
 O
bs
tr
uc
tiv
e 
P
ul
m
on
ar
y 
D
is
ea
se
 d
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//w
w
w
.d
ov
ep
re
ss
.c
om
/ b
y 
13
0.
22
5.
19
8.
24
5 
on
 2
8-
Ju
n-
20
19
F
or
 p
er
so
na
l u
se
 o
nl
y.
Powered by TCPDF (www.tcpdf.org)
                               1 / 1
The combined effect of seasons and countries on physical
activity was analyzed with two-way ANOVA. A P-value
<0.05 was considered significant for all tests. All statistical
analyses were performed with IBM SPSS Statistics
Version 25 (IBM Corporation, Armonk, NY, USA).
Results
Participant characteristics
In total 168 participants with moderate to severe COPD
from Norway, Denmark, and Australia were included
(Table 1). The Australian sample consisted of 61 partici-
pants from the HomeBase study and 33 participants from
the iTrain study, while samples for Norway (N=38) and
Denmark (N=36) consisted only of participants from the
iTrain study. Demographics for the three groups were
generally similar, although the percentage of participants
in GOLD stage III and IV (severe and very severe airflow
limitation) was higher among the Danish participants.
Australian participants had the highest number of comor-
bidities and Danish participants had a lower functional
walking capacity.
Differences in physical activity levels
across countries
All subjects had valid physical activity measurements
from 5 days including 1 weekend day with recordings of
≥12 hours per day. There was a statistically significant
difference in wear time between all countries (P=0.001).
Danish participants wore the activity monitor the most.
Physical activity levels were higher for Norwegian and
Australian participants compared to Danish participants
(Table 2). Danish participants had a lower number of
daily steps, less time spent in MVPA, and more awake
sedentary time compared to the Australians (F(2,165)
=3.760, P=0.025, F(2,165)=4.347, P=0.014 and F(2,165)
=4.693, P=0.010, respectively). After controlling for
FEV1, differences in time spent in MVPA and awake
sedentary time across countries persisted (F(2,168)
=3.800, P=0.024 and F(2,168)=4.431, P=0.013, respec-
tively), while the difference for daily number of steps
was no longer statistically significant.
Effect of seasonal variations on physical
activity levels
The median (IQR) number of steps for all patients was
highest in summer (3,502; 1,253–5,407 steps/day) with
lower levels in spring (2,698; 1,613–5,207 steps/day),
winter (2,373; 1,145–4,206 steps/day) and autumn
(1,603; 738–4,040 steps/day), F(3,164)=2.109, P=0.101.
The difference between summer and other seasons
exceeded the minimal clinically important difference of
600 steps/day.31 Total MVPA time was also highest during
summer. Nevertheless, there were no statistically signifi-
cant differences among seasons for any of the physical
activity variables (Table 3).
Results from the two-way ANOVA showed that there
was no significant effect for the interaction between coun-
try and seasons on the number of steps (P=0.432), with no
significant main effect for season (P=0.273), but a signifi-
cant main effect for country was confirmed (P=0.018). The
interaction effect between seasons and country on awake
sedentary time was not statistically significant (P=0.774).
There was no significant main effect for season (P=0.936),
but a significant main effect for country was confirmed
(P=0.044). The interaction effect between seasons and
country on MVPA time was not statistically significant
(P=0.801). There was no significant main effect for season
(P=0.633), but there was a significant main effect for
country (P=0.042).
Discussion
This study aimed to investigate whether there were differ-
ences in physical activity levels between Norwegian,
Danish and Australian people with COPD. The results
revealed some differences across countries after control-
ling for disease severity. Danish participants spent more
time in an awake sedentary state and less time in MVPA.
The study aimed at establishing whether variations in
physical activity levels were attributable to seasons.
Although it did not reach statistical significance, partici-
pants walked more and with higher intensity during sum-
mer when compared to spring, winter and autumn,
regardless of geography.
Differences in physical activity levels across countries,
as seen in this study, have been observed before. A study on
participation in physical activity among Austrian and
Brazilian people with COPD, suggested that Brazilian par-
ticipants, due to lower socioeconomic status, may ambulate
more for daily activities and to access public transportation
than the Austrians who more often had access to their own
cars.12 In our study, the countries involved have similar
prosperity indexes and socioeconomic standards,32 while
there were differences in disease severity among partici-
pants. Disease severity has been shown to have a weak-to-
moderate positive association with reduced physical activity
Hoaas et al Dovepress
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Table 1 Characteristics of participants with COPD from Norway, Denmark and Australia
Norway
(N=38)
Denmark
(N=36)
Australia
(N=94)
P-value Post hoca
Sex, male 24 (63%) 20 (55%) 52 (55%) 0.696
Age, year 66 (63–72) 63 (61–68) 66 (60–73) 0.211
BMI, kg/m2 28.4 (24.0–33.1] 25.6 (22.9–28.0) 26.0 (22.0–30.5) 0.066
Comorbidities, number 2 (1–3) 2 (0–2) 3 (2–4) <0.001 AU vs NO=0.009
DK vs AU=0.001
Smoking status 0.085
Current smoker 14 (37%) 13 (36%) 18 (19%)
Ex-smoker 24 (63%) 23 (64%) 73 (78%)
Never smoked 0 (0%) 0 (0%) 3 (3%)
Smoking, pack years 24 (15–40) 40 (25–46) 45 (31–56) <0.001 DK vs NO=0.003
AU vs NO=0.001
FEV1/FVC 52.8 (44.0–59.0) 51.5 (43.0–62.5) 43.5 (34.0–56.0) 0.002 AU vs NO=0.008
DK vs AU=0.002
FEV1, liters 1.32 (0.97–1.82) 0.92 (0.69–1.11) 1.13 (0.86–1.50) <0.001 DK vs NO=0.001
DK vs AU=0.002
FEV1, % predicted 50.7 (38.7–63.8) 32.5 (25.0–41.0) 44.0 (32.0–62.0) <0.001 DK vs NO=0.001
DK vs AU=0.001
FVC, % predicted 74.7 (67.0–90.0) 65.5 (48.5–78.0) 74.0 (62.0–90.0) 0.011 DK vs NO=0.013
DK vs AU=0.004
Disease severity
GOLD II 20 (53%) 3 (8%) 40 (43%) <0.001
GOLD IIII 11 (29%) 15 (42%) 38 (40%)
GOLD IV 7 (18%) 18 (50%) 16 (17%)
Use of LTOT, yes 5 (13%) 9 (25%) 12 (13%) 0.204
MMRC 0.642
Score 0 2 (5%) 2 (6%) 1 (1%)
Score 1 11 (29%) 10 (28%) 40 (43%)
Score 2 12 (32%) 13 (36%) 27 (29%)
Score 3 11 (29%) 10 (28%) 23 (24%)
Score 4 2 (5%) 1 (3%) 3 (3%)
6MWD, meters 416 (350–480) 318 193–383) 427 (358–480) <0.001 DK vs NO=0.001
DK vs AU=0.001
Lowest SpO2 during 6MWD, % 90 (86–93) 90 (86–92) 90 (86–93) 0.978
Max HR during 6MWD, beats per minute 112 (99–127) 115 (106–122) 113 (102–122) 0.889
SOB end of 6MWD, Borg CR-10 scale 5 (4–7) 3 (2–3) 4 (3–5) <0.001 DK vs NO=0.001
DK vs AU=0.002
RPE end of 6MWD, Borg CR-10 scaleb 4 (2–6) 3 (2–4) 3 (2–5) 0.432
Gait aid, yes 2 (5%) 6 (17%) 8 (9%) 0.218
Notes: aOnly significant comparisons are listed. bFor the Australian participants, this variable was only calculated for the 33 participants in the iTrain study. Data is presented
as median (IQR) for continuous variables, and counts (percentages) for categorical variables. A pack year is defined as twenty cigarettes smoked every day for one year.
Abbreviations: BMI, body mass index; FEV1, forced expiratory volume in the first second; FVC, forced vital capacity; LTOT, long-term oxygen therapy; MMRC, modified
version of the Medical Research Council Scale; 6MWD, 6 minutes walking distance; SpO2, peripheral capillary oxygen saturation; HR, heart rate; SOB, rating of perceived
shortness of breath; RPE, rating of perceived exertion for leg fatigue; DK, Denmark; NO, Norway; AU, Australia.
Dovepress Hoaas et al
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in patients with COPD.5,33 This partially explained the
differences in physical activity in the current study, as the
Danish participants, who had higher sedentary time and
lower MVPA time, also had more severe COPD than their
counterparts in Norway and Australia. As disease severity
may influence physical activity, it is important to take this
into account in clinical studies, and ensure that participants
are properly stratified to achieve similarity between groups
in multicenter and multinational trials.
For the healthy population, the country of residence
seems to influence self-reported physical activity more
than in people with COPD. According to the Global
Observatory for Physical Activity, 53% of the Norwegian
population and 76% of the Danish population report being
physical active compared with only 43% of the Australian
population.34 However, these findings are based on self-
reported data and may not be as accurate as our objectively
measured data as large variations between self-reported
Table 2 Physical activity among participants from Norway, Denmark and Australia
Norway
N=38
Denmark
N=36
Australia
N=94
P-value Post hoc P-value after
controlling
for FEV1
Wear time, minutes/day 1,361
(1,340–1,414)
1,429
(1,408–1,437)
1,418
(1,401–1,429)
0.001 DK vs NO&AU
NO vs AU
Energy expenditure, kJ/day 9790
(8,237–11,754)
8439
(7,772–9,641)
8320
(7,569–10,843)
0.266 0.288
Steps,
number/day
1672
(1,020–3,839)
1534
(778–3,194)
2916
(1,316–4,986)
0.025 DK vs AU 0.133
Awake sedentary time, minutes/day 775
(626–877)
784
(660–952)
703
(613–802)
0.010 DK vs AU 0.013
Total LIPA,
minutes/daya
158
(81–219)
178
(124–234)
208
(132–249)
0.388 0.422
Total MVPA, minutes/day 30
(7–93)
21
(4–73)
48
(19–98)
0.014 DK vs AU 0.024
Time in MVPA bouts, minutes/day 8
(0–30)
4
(0–26)
7
(0–24)
n.a. n.a.
Notes: DK vs NO&AU, NO vs AU and DK vs AU = P-value ≤0.050, only significant comparisons are listed. aLIPA for the Australian sample was available for the 33
participants in the iTrain study only. Data are median (IQR).
Abbreviations: LIPA, light-intensity physical activity; MVPA, moderate-to-vigorous physical activity; n.a., nonapplicable; DK, Denmark; NO, Norway; AU, Australia.
Table 3 Physical activity in the different seasons
Winter N=50
(NO=12; DK=8;
AU=30)
Spring N=40
(NO=11; DK=8;
AU=21)
Summer N=22
(NO=0; DK=4;
AU=18)
Autumn N=56
(NO=15; DK=16;
AU=25)
P-
value
Energy expenditure,
kJ/day
9075
(7,796–10,297)
8571
(7,748–11,783)
8491
(7,642–11,164)
8442
(7,261–10,314)
0.181
Steps,
number/day
2373
(1,145–4,206)
2698
(1,613–5,207)
3502
(1,253–5,407)
1603
(738–4,04)
0.101
Awake sedentary time, min-
utes/day
721
(608–868)
755
(635–901)
700
(617–801)
735
(620–824)
0.796
Sleep time,
minutes/day
410
(316–463)
362
(316–451)
365
(317–481)
401
(314–463)
0.982
Total LIPA,
minutes/daya
160
(102–237)
197
(150–255)
159
(99–251)
177
(106–230)
0.487
Total MVPA,
minutes/day
39
(15–88)
38
(20–100)
62
(11–108)
27
(8–90)
0.326
Time in MVPA bouts,
minutes/day
9
(0–23)
7
(0–34)
7
(2–25)
5
(0–25)
n.a.
Notes: aLIPA for the Australian sample was available for the 33 participants in the iTrain study only. Data are presented as median (IQR).
Abbreviations: LIPA, light-intensity physical activity; MVPA, moderate-to-vigorous physical activity; n.a., nonapplicable; NO, Norway; DK, Denmark; AU, Australia.
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and accelerometer-measured physical activity and seden-
tary time have been reported.35
In our study, the difference in awake sedentary time and
time spent in MVPA persisted across countries after con-
trolling for disease severity. Danish participants, who spent
significantly longer periods of the day in sedentary activities
and less time walking at higher intensities, had significantly
lower functional walking capacity (indicated by 6MWD)
than participants from other countries. There is a moderate
association between physical activity and physical
capacity.5 In the current study, participants from Norway
and Australia had a median walking distance of >400 m on
the 6MWD and achieved ≥30 minutes of MVPA, whereas
Danish participants walked a median of <400 meters and
did not meet the value of ≥30 minutes of MVPA which is
recommended by the American College of Sports
Medicine.36 Such correlation between physical capacity
and intensity of physical activity has previously been
observed by Pitta et al.2 However, high physical capacity
does not always translate into higher levels of physical
activity, as physical activity is also influenced by psycholo-
gical factors like habit, self-efficacy and health beliefs.37,38
Reducing sedentary time can decrease cardiovascular
risk in other patient groups.39 As many patients with
COPD have cardiovascular comorbidities,40 strategies to
reduce sedentary time may be clinically relevant in
COPD.41 Targeting sedentary behavior can also be effec-
tive in improving the ability to stand up from a seated
position among older adults, thus improving physical
functioning.42 A recent review suggests that future trials
should examine sedentary time as an outcome when asses-
sing physical activity interventions as this may have clin-
ical benefits for people with COPD.41 In the current study,
variations in step count across the year were not offset by
changes in awake sedentary time, as sedentary time was
unchanged all year. Strategies that target sedentary beha-
vior might have a potential for increasing overall physical
activity.
Climate and variations in weather conditions following
the different seasons may influence levels of daily physical
activity in COPD.5 Studies have reported a lower number
of steps during rainy and colder days, in winter and during
extreme summer heat.14,16,17,43,44 A recent study of people
with COPD residing in Canada reported that an increase in
daytime temperature of 10°C translated into 316 more
daily steps (6.6% of mean steps/day) whereas rainfall of
10 mm had a negative effect of 175 less daily steps (3.6%
of mean steps/day).16 The current study was conducted in
three countries with climate zones spanning from an Arctic
climate with cold summers and cold winters to tropically
influenced climate with warm summers and mild winters.
Participants with COPD walked more during summer than
during spring, winter and autumn, regardless of location.
Results did not reach statistical significance perhaps due to
the modest sample size in each group. However, the over-
all difference between summer (3,502 steps/day) and win-
ter (2,373 steps/day) exceeded the minimal clinical
important difference (between 600 and 1,100 steps/day)
in daily step count after pulmonary rehabilitation.31 An
improvement of more than 600 steps/day after pulmonary
rehabilitation is also reported to reduce the risk of hospi-
talization in patients with COPD.31 We therefore consider
the difference of 1,129 daily steps between summer and
winter to be of clinical relevance. In the current study, time
spent in MVPA during winter was also found to be 37%
lower than in summer. Interestingly, another study found a
significant reduction of the time spent actively during
winter when compared to summer among both Brazilian
and Belgian people with COPD. Such a difference was
even more evident in patients from Brazil (20% vs 12% in
Belgium), although Brazil has lower variations in tempera-
ture between summer and winter than Belgium.17 In the
current study, the data collected during winter had a higher
percentage of participants from the Nordic countries than
those collected during summer. This may, in part, explain
the difference with the findings from Furlanetto et al.17
Seasonal differences have implications for clinical
trials that measure physical activity over time, as the
season in which the measurement is taken may influence
outcomes irrespective of any intervention delivered. The
effect of temperature and season on daily steps has
recently been reported in a 3-month physical activity inter-
vention trial on people with COPD.45 An increase in daily
steps was found in subgroup analysis of both a group
receiving a pedometer and web-based support and of a
group receiving a pedometer intervention alone during
the transition from spring to summer. During the transition
from summer to autumn, the group with web-based sup-
port experienced an increase in daily step count from
baseline, while the group using only pedometer had a
significant decline.45 The influence of seasonal variations
on physical activity habits may be relevant for selected
patient groups, such as COPD, as well as for the healthy
population. Results from multinational trials as well as
health registries where physical activity is an outcome
should take into account differences in physical activity
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patterns due to seasonal variations both if the trial is
performed across countries or within one country.
Study strengths and limitations
This study included a cross-sectional convenient sample of
168 participants from three countries. Study subjects were
participants enrolled in two separate trials using common
inclusion criteria, methods and algorithms for objectively
measurements of physical activity. This allowed us to
investigate differences in physical activity across countries
based on a larger sample than that from a single trial.
Differences in disease severity between participants in
the different countries were found, and as a consequence
controlled for. The study also has some limitations. Danish
participants wore the activity monitor for longer each day,
and by this, they might have recorded longer time in
sedentary activities than their counterparts might. Sample
power was not computed beforehand, and the lower num-
ber of Nordic patients with physical activity data collected
during summer may have influenced the results on seaso-
nal variations. Recruitment during summer was low due to
summer holiday both for healthcare personnel supporting
the recruitment procedures and potential participants. We
recommend that future studies investigating seasonal var-
iation will be attentive to include enough participants in
each season. The majority of the physical activity vari-
ables in the dataset were characterized by a non-normal
distribution. We therefore transformed those variables to
achieve normal distribution and use parametric tests.
However, similar results were achieved by use of nonpara-
metric tests. These data represent cross- sectional observa-
tions rather than assessment of the longitudinal impact of
seasons on a given individual. Further studies taking into
account seasonal effects on changes in physical activity
over time are required.
Conclusion
In this cross-sectional study, time spent in awake sedentary
time was greater in Danish participants compared to the
Norwegian and Australian participants after controlling for
disease severity, whilst time spent in MVPA was lower.
The number of steps for all patients was highest in summer
with lower levels in spring, winter and autumn, regardless
of geography. In particular, the overall difference between
summer and winter exceeded the minimal clinical impor-
tant difference in daily step count after pulmonary rehabi-
litation. Weather conditions and seasonal variations may
influence outcomes in clinical trials and health registries
measuring physical activity over time, irrespective of the
interventions delivered, and should be taken into account
when interpreting results.
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